Serum-soluble interleukin-2 receptor in patients with hepatolithiasis: A preliminary report

Shyr Ming Sheen-Chen, Hock Liew Eng, Fong Fu Chou, Wei Jen Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background/Aims: Hepatolithiasis is prevalent in Southeast Asia and remains a difficult problem to manage. Recent studies in immunology have provided evidence for the provocative roles of cytokines in many diseases. This study was designed to explore the possible relationship between the serum-soluble interleukin-2 receptor and the pathogenesis of hepatolithiasis. Methodology: In this pilot study, 34 patients with hepatolithiasis were included. All of the patients met the following criteria: (1) presence of hepatolithiasis; (2) no obvious clinical evidence of associated intrahepatic cholangiocarcinoma; (3) no clinical manifestation of cholangitis for at least 72 hours; (4) no intake of immunomodulatory agents in the previous 3 weeks; and (5) no blood transfusions in the previous 3 weeks. Venous blood samples were collected before surgery, and the concentrations of serum soluble interleukin-2 receptor were measured with an enzyme immunoassay method. Fifteen healthy subjects were used as the control group. Bile specimens routinely obtained during surgery were cultured for aerobes and anaerobes. The cholangiography films were reviewed in detail. Results: The mean value of soluble interleukin-2 receptor in patients with hepatolithiasis was 706 ± 294 units/ml, and that of the control group was 326 ± 62 units/ml. The difference was significant (p < 0.01). Bacteria were present in the bile of all patients. The total number of bacterial species in the 34 patients was 119, and there was an average of 3.5 bacterial species cultured per patient. Intrahepatic bile duct strictures were present in 30 patients (88%). Conclusions: In addition to a high incidence of intrahepatic bile duct strictures and bacterial infection of the bile, significantly high levels of the serum soluble interleukin-2 receptor were also found in the patients with hepatobithiasis. The preliminary results in the present study seem to be promising, and the specific role of the soluble interleukin-2 receptor in patients with hepatolithiasis deserves further investigation and elucidation.

Original languageEnglish
Pages (from-to)196-200
Number of pages5
JournalHepato-Gastroenterology
Volume45
Issue number19
Publication statusPublished - Feb 19 1998
Externally publishedYes

Fingerprint

Interleukin-2 Receptors
Serum
Bile
Intrahepatic Bile Ducts
Pathologic Constriction
Southeastern Asia
Control Groups
Cholangitis
Cholangiocarcinoma
Cholangiography
Allergy and Immunology
Immunoenzyme Techniques
Bacterial Infections
Blood Transfusion
Healthy Volunteers
Cytokines
Bacteria
Incidence

Keywords

  • Hepatolithiasis
  • Oluble interleukin-2 receptor

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Serum-soluble interleukin-2 receptor in patients with hepatolithiasis : A preliminary report. / Sheen-Chen, Shyr Ming; Eng, Hock Liew; Chou, Fong Fu; Chen, Wei Jen.

In: Hepato-Gastroenterology, Vol. 45, No. 19, 19.02.1998, p. 196-200.

Research output: Contribution to journalArticle

Sheen-Chen, Shyr Ming ; Eng, Hock Liew ; Chou, Fong Fu ; Chen, Wei Jen. / Serum-soluble interleukin-2 receptor in patients with hepatolithiasis : A preliminary report. In: Hepato-Gastroenterology. 1998 ; Vol. 45, No. 19. pp. 196-200.
@article{a67e577e240c41ffb2f869697a3162d9,
title = "Serum-soluble interleukin-2 receptor in patients with hepatolithiasis: A preliminary report",
abstract = "Background/Aims: Hepatolithiasis is prevalent in Southeast Asia and remains a difficult problem to manage. Recent studies in immunology have provided evidence for the provocative roles of cytokines in many diseases. This study was designed to explore the possible relationship between the serum-soluble interleukin-2 receptor and the pathogenesis of hepatolithiasis. Methodology: In this pilot study, 34 patients with hepatolithiasis were included. All of the patients met the following criteria: (1) presence of hepatolithiasis; (2) no obvious clinical evidence of associated intrahepatic cholangiocarcinoma; (3) no clinical manifestation of cholangitis for at least 72 hours; (4) no intake of immunomodulatory agents in the previous 3 weeks; and (5) no blood transfusions in the previous 3 weeks. Venous blood samples were collected before surgery, and the concentrations of serum soluble interleukin-2 receptor were measured with an enzyme immunoassay method. Fifteen healthy subjects were used as the control group. Bile specimens routinely obtained during surgery were cultured for aerobes and anaerobes. The cholangiography films were reviewed in detail. Results: The mean value of soluble interleukin-2 receptor in patients with hepatolithiasis was 706 ± 294 units/ml, and that of the control group was 326 ± 62 units/ml. The difference was significant (p < 0.01). Bacteria were present in the bile of all patients. The total number of bacterial species in the 34 patients was 119, and there was an average of 3.5 bacterial species cultured per patient. Intrahepatic bile duct strictures were present in 30 patients (88{\%}). Conclusions: In addition to a high incidence of intrahepatic bile duct strictures and bacterial infection of the bile, significantly high levels of the serum soluble interleukin-2 receptor were also found in the patients with hepatobithiasis. The preliminary results in the present study seem to be promising, and the specific role of the soluble interleukin-2 receptor in patients with hepatolithiasis deserves further investigation and elucidation.",
keywords = "Hepatolithiasis, Oluble interleukin-2 receptor",
author = "Sheen-Chen, {Shyr Ming} and Eng, {Hock Liew} and Chou, {Fong Fu} and Chen, {Wei Jen}",
year = "1998",
month = "2",
day = "19",
language = "English",
volume = "45",
pages = "196--200",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "19",

}

TY - JOUR

T1 - Serum-soluble interleukin-2 receptor in patients with hepatolithiasis

T2 - A preliminary report

AU - Sheen-Chen, Shyr Ming

AU - Eng, Hock Liew

AU - Chou, Fong Fu

AU - Chen, Wei Jen

PY - 1998/2/19

Y1 - 1998/2/19

N2 - Background/Aims: Hepatolithiasis is prevalent in Southeast Asia and remains a difficult problem to manage. Recent studies in immunology have provided evidence for the provocative roles of cytokines in many diseases. This study was designed to explore the possible relationship between the serum-soluble interleukin-2 receptor and the pathogenesis of hepatolithiasis. Methodology: In this pilot study, 34 patients with hepatolithiasis were included. All of the patients met the following criteria: (1) presence of hepatolithiasis; (2) no obvious clinical evidence of associated intrahepatic cholangiocarcinoma; (3) no clinical manifestation of cholangitis for at least 72 hours; (4) no intake of immunomodulatory agents in the previous 3 weeks; and (5) no blood transfusions in the previous 3 weeks. Venous blood samples were collected before surgery, and the concentrations of serum soluble interleukin-2 receptor were measured with an enzyme immunoassay method. Fifteen healthy subjects were used as the control group. Bile specimens routinely obtained during surgery were cultured for aerobes and anaerobes. The cholangiography films were reviewed in detail. Results: The mean value of soluble interleukin-2 receptor in patients with hepatolithiasis was 706 ± 294 units/ml, and that of the control group was 326 ± 62 units/ml. The difference was significant (p < 0.01). Bacteria were present in the bile of all patients. The total number of bacterial species in the 34 patients was 119, and there was an average of 3.5 bacterial species cultured per patient. Intrahepatic bile duct strictures were present in 30 patients (88%). Conclusions: In addition to a high incidence of intrahepatic bile duct strictures and bacterial infection of the bile, significantly high levels of the serum soluble interleukin-2 receptor were also found in the patients with hepatobithiasis. The preliminary results in the present study seem to be promising, and the specific role of the soluble interleukin-2 receptor in patients with hepatolithiasis deserves further investigation and elucidation.

AB - Background/Aims: Hepatolithiasis is prevalent in Southeast Asia and remains a difficult problem to manage. Recent studies in immunology have provided evidence for the provocative roles of cytokines in many diseases. This study was designed to explore the possible relationship between the serum-soluble interleukin-2 receptor and the pathogenesis of hepatolithiasis. Methodology: In this pilot study, 34 patients with hepatolithiasis were included. All of the patients met the following criteria: (1) presence of hepatolithiasis; (2) no obvious clinical evidence of associated intrahepatic cholangiocarcinoma; (3) no clinical manifestation of cholangitis for at least 72 hours; (4) no intake of immunomodulatory agents in the previous 3 weeks; and (5) no blood transfusions in the previous 3 weeks. Venous blood samples were collected before surgery, and the concentrations of serum soluble interleukin-2 receptor were measured with an enzyme immunoassay method. Fifteen healthy subjects were used as the control group. Bile specimens routinely obtained during surgery were cultured for aerobes and anaerobes. The cholangiography films were reviewed in detail. Results: The mean value of soluble interleukin-2 receptor in patients with hepatolithiasis was 706 ± 294 units/ml, and that of the control group was 326 ± 62 units/ml. The difference was significant (p < 0.01). Bacteria were present in the bile of all patients. The total number of bacterial species in the 34 patients was 119, and there was an average of 3.5 bacterial species cultured per patient. Intrahepatic bile duct strictures were present in 30 patients (88%). Conclusions: In addition to a high incidence of intrahepatic bile duct strictures and bacterial infection of the bile, significantly high levels of the serum soluble interleukin-2 receptor were also found in the patients with hepatobithiasis. The preliminary results in the present study seem to be promising, and the specific role of the soluble interleukin-2 receptor in patients with hepatolithiasis deserves further investigation and elucidation.

KW - Hepatolithiasis

KW - Oluble interleukin-2 receptor

UR - http://www.scopus.com/inward/record.url?scp=0031911114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031911114&partnerID=8YFLogxK

M3 - Article

C2 - 9496512

AN - SCOPUS:0031911114

VL - 45

SP - 196

EP - 200

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 19

ER -